RAS P21 EXPRESSION IN RELATION TO HISTOPATHOLOGICAL VARIABLES AND PROGNOSIS IN COLORECTAL ADENOCARCINOMA

被引:11
|
作者
SUN, XF
HATSCHEK, T
WINGREN, S
STAL, O
CARSTENSEN, JM
ZHANG, H
BOERYD, B
SJODAHL, R
NORDENSKJOLD, B
机构
[1] LINKOPING UNIV HOSP,DEPT PATHOL,S-58185 LINKOPING,SWEDEN
[2] LINKOPING UNIV HOSP,DEPT SURG,S-58185 LINKOPING,SWEDEN
关键词
RAS P21; HISTOPATHOLOGY; PROGNOSIS; COLORECTAL ADENOCARCINOMA; IMMUNOHISTOCHEMISTRY;
D O I
10.3109/02841869109088246
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ras gene protein products (p21) reacting with the monoclonal antibodies ras 11, DWP, R256 and E184 were studied with an immunohistochemical method which was applied to 17 normal and 79 colorectal adenocarcinoma specimens. Normal colorectal epithelium showed positive staining for ras 11 in 35% of the cases, but not for DWP, R256 and E184. The antibodies showed positive staining in colorectal adenocarcinomas in 76, 53, 29 and 35% of the cases respectively. The degree of staining for ras 11 was significantly related to the grade of differentiation and increased from Dukes stage A to C. Strong staining for ras 11 predicted a significantly shorter recurrence-free interval (p < 0.001). In Cox's regression analysis, the degree of staining for ras 11 was a prognostic factor independent of the grade of differentiation and Dukes stage (p < 0.01). The results indicate that the enhanced expression of pan ras p21 may provide an important biological marker for determining prognosis in colorectal adenocarcinomas.
引用
收藏
页码:933 / 939
页数:7
相关论文
共 50 条
  • [41] p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma
    Burton, JL
    Stewart, RL
    Heatley, MK
    Royds, JA
    Wells, M
    HISTOPATHOLOGY, 1999, 35 (03) : 221 - 229
  • [42] Down-expression of p27 and expression of p21 are associated with the adenocarcinoma of the gallbladder
    Zhang, S
    Hiremath, P
    Gao, XZ
    Ferrer, K
    Sekosan, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (04) : 654 - 655
  • [43] Cyclin D1 and p21 expression in gastric adenocarcinoma
    Kim, SJ
    Mok, YJ
    Lee, JB
    Kim, CS
    Koo, BH
    Kim, SM
    Kim, SH
    Song, TJ
    Kim, DH
    Chae, YS
    Choi, IS
    Son, GS
    3RD INTERNATIONAL GASTRIC CANCER CONGRESS, 1999, : 359 - 364
  • [44] Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2, p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma
    Sun, XF
    Carstensen, JM
    Stal, O
    Zhang, H
    Nordenskjold, B
    INTERNATIONAL JOURNAL OF CANCER, 1996, 69 (01) : 5 - 8
  • [45] Relationship Between Expression of ras p21 Oncoprotein and Mutation Status of the K-ras Gene in Sporadic Colorectal Cancer Patients in Tunisia
    Sammoud, Souraya
    Khiari, Meriem
    Semeh, Amara
    Amine, Lounis
    Ines, Chaar
    Amira, Arfaoui
    Lilia, Kriaa
    Taher, Khalfallah
    Sabeh, Mzabi
    Saadia, Bouraoui
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (02): : 146 - 152
  • [46] QUANTITATION OF RAS P21 PROTEIN - REPLY
    QUERZOLI, P
    MARCHETTI, E
    BAGNI, A
    MARZOLA, A
    FABRIS, G
    NENCI, I
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 16 (03) : 291 - 291
  • [47] INDUCTION OF P21(RAS) IN ALZHEIMER PATHOLOGY
    GARTNER, U
    HOLZER, M
    HEUMANN, R
    ARENDT, T
    NEUROREPORT, 1995, 6 (10) : 1441 - 1444
  • [48] ACTIVATION OF CELLULAR P21 RAS BY MYRISTOYLATION
    BUSS, JE
    SOLSKI, PA
    SCHAEFFER, JP
    MACDONALD, MJ
    DER, CJ
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1989, 17 (05) : 867 - 869
  • [49] ACTIVATORS AND EFFECTORS OF RAS P21 PROTEINS
    MCCORMICK, F
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (01) : 71 - 76
  • [50] EXPRESSION OF RAS ONCOGENE P21 ANTIGEN IN NORMAL AND PROLIFERATIVE THYROID TISSUES
    JOHNSON, TL
    LLOYD, RV
    SISSON, JC
    BEIERWALTES, WH
    THOMPSON, NW
    THOR, A
    SCHLOM, J
    LABORATORY INVESTIGATION, 1986, 54 (01) : A29 - A29